ZZ Biotech

ZZ Biotech is a pioneering pharmaceutical manufacturing company focused on developing innovative therapies for significant medical needs. ZZ Biotech's lead program centers around 3K3A-APC, a genetically engineered variant of human activated protein C (APC), a serine protease meticulously optimized for therapeutic applications in humans. ZZ Biotech is dedicated to pushing the boundaries of medical science to create impactful treatments that improve patient outcomes.

ZZ Biotech is pleased to announce an agreement in principle to license its 3K3A-APC program in dermatology to Dermatherix, Pty Ltd. Dermatherix is known as a pioneering biotech company dedicated to advancing wound therapies through innovative research. This collaboration promises to accelerate the development and delivery of advanced wound care solutions to those who need them most. ZZ Biotech is excited to see its drug 3K3A-APC advanced by the team at Dermatherix.

With a strong commitment to innovation and collaboration, ZZ Biotech continues to explore new avenues for growth and development in the pharmaceutical sector. The company's expertise in biologics and dedication to addressing critical medical challenges position it as a key player in the industry. We invite the management team at ZZ Biotech to create a customized and exclusive company showcase and product listing on our platform to further enhance your market presence.